Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 3/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | MGAM | O43451 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 1/20 | 0.38 |
| ▸ | SI | P14410 | 1/20 | 0.38 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.38 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL144551 | 0.84 | — | — | |
| SCHEMBL10555486 | 0.81 | ALDH1A1 (0.64) | CES2CES1ACHELMNANPC1 | |
| SCHEMBL4755295 | 0.81 | CYP2A6 (0.47) | ACHECYP2A6TDP1CYP1A2TSHR | |
| SCHEMBL1317463 | 0.81 | CYP2A6 (0.47) | ACHECYP2A6TDP1CYP1A2TSHR | |
| SCHEMBL6203955 | 0.81 | — | — | |
| SCHEMBL12679 | 0.81 | — | — | |
| 1,4-Dichlorobenzene SCHEMBL6273412 | 0.80 | TSHR (0.42) | ACHECYP2A6LMNANPC1RAB9A | |
| SCHEMBL10736300 | 0.78 | CES2 (0.45) | CES2CES1ACHECYP2A6LMNA | |
| Bromide SCHEMBL28687084 | 0.78 | CES2 (0.59) | CES2CES1ACHECYP2A6LMNA | |
| Phosphine SCHEMBL22129260 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1818332-B1 | PROCESS FOR PRODUCING EPOXYTRIAZOLE DERIVATIVE | SUMITOMO CHEMICAL CO (JP) | 2011-04-13 | — | — | EP | disclosed |
| US-7569699-B2 | Process for producing epoxytriazole derivative | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-08-04 | — | — | US | disclosed |
| US-20080081915-A1 | Process For Producing Epoxytriazole Derivative | SUMITOMO CHEMICAL COMPANY, LIMITED | 2008-04-03 | — | — | US | disclosed |
| EP-1818332-A1 | PROCESS FOR PRODUCING EPOXYTRIAZOLE DERIVATIVE | Sumitomo Chemical Company, Limited (JP) | 2007-08-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080081915-A1 | Process For Producing Epoxytriazole Derivative | CYP2E1, CYP1A1, SULT1A1 | CES2 796/4885CES1 750/4885ACHE 3331/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.